EP-4679094-A3 - METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO PROGRAMMED DEATH-1 RECEPTOR (PD-1) OR PROGRAMMED DEATH LIGAND 1 (PD-L1)
EP4679094A3EP 4679094 A3EP4679094 A3EP 4679094A3EP-4679094-A3
Abstract
This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g ., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g ., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
Inventors
- MANEKAS, Demetrios
- GROSSO, Joseph
- ANDERSON, JEFFREY
Assignees
- Bristol-Myers Squibb Company
Dates
- Publication Date
- 20260513
- Application Date
- 20160714